Cargando…

Reverse the Resistance to PARP Inhibitors

One of the DNA repair machineries is activated by Poly (ADP-ribose) Polymerase (PARP) enzyme. Particularly, this enzyme is involved in repair of damages to single-strand DNA, thus decreasing the chances of generating double-strand breaks in the genome. Therefore, the concept to block PARP enzymes by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Yevgeniy, Kim, Aleksei, Sharip, Ainur, Sharip, Aigul, Jiang, Juhong, Yang, Qing, Xie, Yingqiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332874/ https://www.ncbi.nlm.nih.gov/pubmed/28255272 http://dx.doi.org/10.7150/ijbs.17240

Ejemplares similares

Analysis of origin and protein-protein interaction maps suggests distinct oncogenic role of nuclear EGFR during cancer evolution
por: Sharip, Ainur, et al.
Publicado: (2017)

Understanding the Pathogenesis of Spondyloarthritis
por: Sharip, Aigul, et al.
Publicado: (2020)

Meta-Analysis of Esophageal Cancer Transcriptomes Using Independent Component Analysis
por: Ashenova, Ainur, et al.
Publicado: (2021)

re-Searcher: GUI-based bioinformatics tool for simplified genomics data mining of VCF files
por: Karabayev, Daniyar, et al.
Publicado: (2021)

Whole-genome sequencing data of Kazakh individuals
por: Kairov, Ulykbek, et al.
Publicado: (2021)

IBD in the elderly - beware of pitfalls!
por: Sharip, Mohmmed T., et al.
Publicado: (2023)

Latex Anaphylaxis Caused by Occupational Exposure to Balloons
por: West, Robert W, et al.
Publicado: (2022)

Return to Work, Demographic Predictors, and Symptomatic Analysis Among Healthcare Workers Presenting for COVID-19 Testing: A Retrospective Cohort From a United States Academic Occupational Medicine Clinic
por: Chaudhry, Zaira S, et al.
Publicado: (2021)

Whole-Genome Sequencing and Genomic Variant Analysis of Kazakh Individuals
por: Kairov, Ulykbek, et al.
Publicado: (2022)

PARP Inhibitors Resistance: Mechanisms and Perspectives
por: Giudice, Elena, et al.
Publicado: (2022)

The impact on life cycle carbon footprint of converting from disposable to reusable sharps containers in a large US hospital geographically distant from manufacturing and processing facilities
por: McPherson, Brett, et al.
Publicado: (2019)

The Role of Virtual Reality as a Psychological Intervention for Mental Health Disturbances during the COVID-19 Pandemic: A Narrative Review
por: Hatta, Muhammad Hizri, et al.
Publicado: (2022)

Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance
por: Kim, Dae-Seok, et al.
Publicado: (2021)

PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms
por: Jiang, Xuan, et al.
Publicado: (2019)

Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer
por: McMullen, Michelle, et al.
Publicado: (2020)

PARP inhibitor resistance: the underlying mechanisms and clinical implications
por: Li, He, et al.
Publicado: (2020)

Role of Akt Activation in PARP Inhibitor Resistance in Cancer
por: Gallyas, Ferenc, et al.
Publicado: (2020)

Mechanisms of resistance to PARP inhibitors - an evolving challenge in oncology
por: Mweempwa, Angela, et al.
Publicado: (2019)

Insights into the Possible Molecular Mechanisms of Resistance to PARP Inhibitors
por: Piombino, Claudia, et al.
Publicado: (2022)

Combination Treatment Strategies to Overcome PARP Inhibitor Resistance
por: Soung, Young-Hwa, et al.
Publicado: (2023)

Role of Biomarkers in the Development of PARP Inhibitors
por: Ganguly, Bratati, et al.
Publicado: (2016)

Modulated nanowire scaffold for highly efficient differentiation of mesenchymal stem cells
por: Perez, Jose E., et al.
Publicado: (2022)

PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs
por: Wang, Luyao, et al.
Publicado: (2017)

Mechanism of PARP inhibitor resistance and potential overcoming strategies
por: Fu, Xiaoyu, et al.
Publicado: (2023)

Clinical use and mechanisms of resistance for PARP inhibitors in homologous recombination-deficient cancers
por: Janysek, Dawn C., et al.
Publicado: (2021)

Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP Inhibitors
por: Lim, Joline S. J., et al.
Publicado: (2017)

Resistance to PARP-Inhibitors in Cancer Therapy
por: Montoni, Alicia, et al.
Publicado: (2013)

Predicting PARP inhibitor sensitivity and resistance
por: Bebb, D. Gwyn, et al.
Publicado: (2012)

Advances and perspectives of PARP inhibitors
por: Yi, Ming, et al.
Publicado: (2019)

PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies
por: Miller, Rowan E, et al.
Publicado: (2022)

PARP Inhibitor Resistance Mechanisms and Implications for Post-Progression Combination Therapies
por: Lee, Elizabeth K., et al.
Publicado: (2020)

Preventing and Overcoming Resistance to PARP Inhibitors: A Focus on the Clinical Landscape
por: Prados-Carvajal, Rosario, et al.
Publicado: (2021)

Pre-Existing and Acquired Resistance to PARP Inhibitor-Induced Synthetic Lethality
por: Le, Bac Viet, et al.
Publicado: (2022)

Fighting resistance: post-PARP inhibitor treatment strategies in ovarian cancer
por: Veneziani, Ana C., et al.
Publicado: (2023)

Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
por: Kim, Hyoung, et al.
Publicado: (2020)

PARP Inhibitors: Clinical Limitations and Recent Attempts to Overcome Them
por: Kim, Dongha, et al.
Publicado: (2022)

Mechanisms of PARP1 inhibitor resistance and their implications for cancer treatment
por: Jackson, Lindsey M, et al.
Publicado: (2022)

Understanding the Turning Point of Patients with Diabetes
por: Hashim, Syahnaz Mohd, et al.
Publicado: (2021)

PARP inhibitors
por: Anwar, Maheen, et al.
Publicado: (2015)

An update on PARP inhibitors for the treatment of cancer
por: Benafif, Sarah, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u0oc63kta9ivvbhfg0me34kutg